CD14+ cell-derived IL-29 modulates proinflammatory cytokine production in patients with allergic airway inflammation

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 2, 2011, Pages 238-246

  He, S ^a,b   Li, T ^c   Chen, H ^b   Ma, W ^a   Yao, Q ^b   Yang, H ^a   Wang, H ^a   Wang, F ^a   Zhao, C ^d   Yang, P ^c  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^c MCMASTER UNIVERSITY   (Canada)

^d SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

allergic disease; CD4 T cell; inflammation; interleukin 29; monocytes

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 29; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; RESPIRATORY TRACT MUCOSA; RNA INTERFERENCE;

ANTIGENS, CD14; ASTHMA; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKINS; SEASONS;

EID: 78651095500     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02455.x     Document Type: Article

References (40)

1. Long AA,. Monoclonal antibodies and other biologic agents in the treatment of asthma. MAbs 2009; 1: 237-246.
2. Ank N, Paludan SR,. Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors 2009; 35: 82-87.
3. Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR, Hartmann R,. Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family. J Biol Chem 2009; 284: 20869-20875.
4. Renauld JC,. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 2003; 3: 667-676.
5. Uzé G, Monneron D,. IL-28 and IL-29: newcomers to the interferon family. Biochimie 2007; 89: 729-734.
6. Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H,. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 2004; 76: 314-321.
7. Pekarek V, Srinivas S, Eskdale J, Gallagher G,. Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. Genes Immun 2007; 8: 177-180.
8. Megjugorac NJ, Gallagher GE, Gallagher G,. Modulation of human plasmacytoid DC function by IFN-lambda1 (IL-29). J Leukoc Biol 2009; 86: 1359-1363.
9. Ziegler T, Matikainen S, Rönkkö E, Osterlund P, Sillanpää M, Sirén J, et al. Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells. J Virol 2005; 79: 13800-13805.
10. Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EE, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201: 1435-1446.
11. Baumgart DC, Thomas S, Przesdzing I, Metzke D, Bielecki C, Lehmann SM, et al. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Clin Exp Immunol 2009; 157: 423-436.
12. Smit LA, Siroux V, Bouzigon E, Oryszczyn MP, Lathrop M, Demenais F, et al. Epidemiological Study on the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and Atopy (EGEA) cooperative group. CD14 and toll-like receptor gene polymorphisms, country living, and asthma in adults. Am J Respir Crit Care Med 2009; 179: 363-368.
13. Asakura H, Suzuki K, Honma T,. Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? World J Gastroenterol 2007; 13: 2145-2149.
14. Robek MD, Boyd BS, Chisari FV,. Lambda interferon inhibits hepatitis B and C virus replication. J Virol 2005; 79: 3851-3854.
15. Doyle SE, Schreckhise H, Khuu-Duong K, Henderson K, Rosler R, Storey H, et al. Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes. Hepatology 2006; 44: 896-906.
16. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4: 69-77.
17. Zitzmann K, Brand S, Baehs S, Goke B, Meinecke J, Spottl G, Meyer H,. Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells. Biochem Biophys Res Commun 2006; 344: 1334-1341.
18. Coccia EM, Severa M, Giacomini E, Monneron D, Remoli ME, Julkunen I, et al. Viral infection and Toll-like receptor agonists induce a differential expression of type I and l interferon as in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 2004; 34: 796-805.
19. Bullens DM, Decraene A, Dilissen E, Coccia EM,. Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics. Clin Exp Allergy 2008; 38: 1459-1467.
20. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006; 12: 1023-1026.
21. Bossios A, Gourgiotis D, Skevaki CL, Saxoni-Papageorgiou P, Lötvall J, Psarras S, et al. Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin-8 release. Clin Exp Allergy 2008; 38: 1615-1626.
22. von Mutius E,. Presentation of new GINA guidelines for paediatrics. The global initiative on asthma. Clin Exp Allergy 2000; 30 (Suppl. 1): 6-10.
23. Demoly P, Allaert FA, Lecasble M, Bousquet J,. PRAGMA. Allergy 2003; 58: 672-675.
24. Liu T, Chen X, Feng BS, He SH, Zhang TY, Wang BQ, Yang PC,. Glucuronoxylomannan promotes the generation of antigen-specific T regulatory cell that suppresses the antigen specific Th2 response upon activation. J Cell Mol Med 2009; 13: 1765-1774.
25. Feng BS, Chen X, He SH, Zheng PY, Foster J, Xing Z, et al. Disruption of T-cell immunoglobulin and mucin domain molecule (TIM)-1/TIM4 interaction as a therapeutic strategy in a dendritic cell-induced peanut allergy model. J Allergy Clin Immunol 2008; 122: 55-61.
26. Jordan WJ, Eskdale J, Srinivas S, Pekarek V, Kelner D, Rodia M, Gallagher G,. Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Genes Immun 2007; 8: 254-261. (Pubitemid 46679436)
27. Srinivas S, Dai J, Eskdale J, Gallagher GE, Megjugorac NJ, Gallagher G,. Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Immunology 2008; 125: 492-502.
28. Dai J, Megjugorac NJ, Gallagher GE, Yu RY, Gallagher G,. IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells. Blood 2009; 113: 5829-5838.
29. Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, et al. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 2009; 5: e1000474.
30. Jang YS, Kim HA, Park SR, Lee MR, Park JB, Kim PH,. IL-4 stimulates mouse macrophages to express APRIL through p38MAPK and two different downstream molecules, CREB and Stat6. Cytokine 2009; 47: 43-47.
31. Junttila IS, Mizukami K, Dickensheets H, Meier-Schellersheim M, Yamane H, Donnelly RP, Paul WE,. Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity. J Exp Med 2008; 205: 2595-2608.
32. Poupot M, Fournié JJ, Poupot R,. Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells. J Leukoc Biol 2008; 84: 1298-1305.
33. Megjugorac NJ, Gallagher GE, Gallagher G,. IL-4 enhances IFN-{lambda}1 (IL-29) production by plasmacytoid DC, via monocyte secretion of IL-1Ra. Blood. 2010; [Epub ahead of print] PMID: 20233967.
34. Sommereyns C, Paul S, Staeheli P, Michiels T,. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 2008; 4: e1000017.
35. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4: 63-68.
36. Sato A, Ohtsuki M, Hata M, Kobayashi E, Murakami T,. Antitumor activity of IFN-lambda in murine tumor models. J Immunol 2006; 176: 7686-7694.
37. Mennechet FJ, Uzé G,. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 2006; 107: 4417-4423.
38. Busse PJ, Zhang TF, Schofield B, Kilaru S, Patil S, Li XM,. Decrease in airway mucous gene expression caused by treatment with anti-tumor necrosis factor alpha in a murine model of allergic asthma. Ann Allergy Asthma Immunol 2009; 103: 295-303.
39. Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfikakis PP, Stratigos AJ,. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol 2009; 61: 486-504.
40. Hoentjen F, van Bodegraven AA,. Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. World J Gastroenterol 2009; 15: 2067-2073.